CYCLIN-DEPENDENT KINASE 9

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 18:49:51 GMT 2025` Edited by `admin` on `Tue Apr 01 18:49:51 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	U3P2YH5TIJ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CYCLIN-DEPENDENT KINASE 9

Common Name

English

C-2K

Preferred Name

English

CDC2L4

Common Name

English

CDK9

Common Name

English

TAK

Common Name

English

SERINE/THREONINE-PROTEIN KINASE PITALRE

Common Name

English

CELL DIVISION CYCLE 2-LIKE PROTEIN KINASE 4

Common Name

English

CELL DIVISION PROTEIN KINASE 9

Common Name

English

TAT-ASSOCIATED KINASE COMPLEX CATALYTIC SUBUNIT

Common Name

English

Code System Code Type Description

FDA UNII

U3P2YH5TIJ

Created by admin on Tue Apr 01 18:49:51 GMT 2025 , Edited by admin on Tue Apr 01 18:49:51 GMT 2025

PRIMARY

UNIPROT

P50750

Created by admin on Tue Apr 01 18:49:51 GMT 2025 , Edited by admin on Tue Apr 01 18:49:51 GMT 2025

PRIMARY

PHAROS

P50750

Created by admin on Tue Apr 01 18:49:51 GMT 2025 , Edited by admin on Tue Apr 01 18:49:51 GMT 2025

PRIMARY

Related Record Type Details


					1255AT22ZJ

Enitociclib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					63Q7F59W0V

ATUVECICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					1GAJ98SC2X

RGB-286638 FREE BASE

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					29713BMI56

ZK-304709

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					0W9Q8U337A

RONICICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					40D08182TT

ZOTIRACICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					4V8ECV0NBQ

DINACICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					L46P54NB4V

BTX-A51

INHIBITOR -> TARGET

Qualification:

Kd

Amount:


					X1BF92PW9T

AT-7519

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					9979I93686

SNS-032

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					0ES1C2KQ94

SELICICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					YET2XNU791

FADRACICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					276Z913G29

AZD-5438

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					45AD6X575G

ALVOCIDIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					MKS45S912B

PHA-793887

INHIBITOR -> TARGET

Amount:


					W66XP666AM

VORUCICLIB

INHIBITOR -> TARGET

Qualification:

Ki

Amount:


					U6072DO9XG

Trilaciclib

INHIBITOR -> TARGET

Amount:


					9EK26WE8QN

RIVICICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					WBH8AY6ENB

LEROCICLIB

INHIBITOR -> TARGET

Amount:


					F7J6KSY5I8

Istisociclib

INHIBITOR -> TARGET

Interaction Type:

IN-VITRO

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO_ACID_SUBSTITUTION	[1_175] [1_353] [1_357]	SITE_SPECIFIC	S		DEXFOSFOSERINE	VI4F0K069V
AMINO_ACID_SUBSTITUTION	[1_350] [1_354] [1_362] [1_363]	SITE_SPECIFIC	T		THREONINE PHOSPHATE	3L4WX7B1EI

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT	CHEMICAL